Head and Neck Cancer Clinical Trials

A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

This phase I trial investigates the side effects of cabozantinib and nivolumab in treating patients with cancer that has spread to other places in the body (advanced) and who are undergoing treatment for human immunodeficiency virus (HIV). Cabozantinib may stop the growth of tumor cells by blocking some of the …

cancer
hepatitis
enzyme-linked immunosorbent assay
investigational new drug
hysterectomy
  • 0 views
  • 26 Sep, 2021
  • 2 locations
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma

This study evaluates the diagnostic accuracy of USPIO enhanced MRI for the detection of lymph node metastases in head-and-neck squamous cell carcinoma (SCC) using histopathology as a gold standard.

caries
metastasis
squamous cell carcinoma
squamous cell carcinoma of the oral cavity
head and neck carcinoma
  • 0 views
  • 23 Sep, 2021
  • 1 location
Testing the Addition of an Anti-cancer Drug BAY 1895344 to the Usual Chemotherapy Treatment (Cisplatin or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

This phase I trial identifies the best dose, possible benefits and/or side effects of BAY 1895344 in combination with chemotherapy in treating patients with solid tumors or urothelial cancer that has spread to other places in the body (advanced). BAY 1895344 may stop the growth of tumor cells by blocking …

  • 0 views
  • 17 Sep, 2021
  • 1 location
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors

Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell cancer or advanced or metastatic cutaneous squamous cell carcinoma.

pembrolizumab
cancer
measurable disease
EGFR
  • 0 views
  • 26 Sep, 2021
  • 4 locations
Comprehensive Swallowing Rehabilitation in Patients With MSA

The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy.

  • 0 views
  • 13 Sep, 2021
  • 1 location
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

This is a multicenter phase 1 trial of INCB7839 for children with recurrent or progressive high-grade gliomas, including, but not limited to, diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMGs), after upfront therapy.

sargramostim
astrocytoma
spinal cord
MRI
anticonvulsants
  • 0 views
  • 26 Sep, 2021
  • 11 locations
Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors

BGB-A425 is a humanized, immunoglobulin gamma-1 (IgG1)-variant monoclonal antibody against TIM-3. Tislelizumab is a humanized, immunoglobulin G4 (IgG4)-variant monoclonal antibody against PD-1. This study tests the safety and anti-tumor effect of BGB-A425 in combination with tislelizumab in participants with advanced solid tumors.

  • 54 views
  • 18 Sep, 2021
  • 21 locations
Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors

The investigational drug to be studied in this protocol, BCA101, is a first-in-class compound that targets both EGFR with TGF. Based on preclinical data, this bifunctional antibody may exert synergistic activity in patients with EGFR-driven tumors.

measurable disease
cancer
pd-l1
monoclonal antibodies
ki-ras
  • 7 views
  • 25 Sep, 2021
  • 6 locations
The Head and Neck Tumor Biobank

The purpose of the biobank is to enable future genomic based research on this Head and Neck Cancer patient population. The investigators will try to identify tumor factors that will predict

cancer
caries
neck cancer
head and neck cancer
  • 2 views
  • 21 Sep, 2021
  • 1 location
Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy

The primary and general objective of the clinical introduction of the Standard Follow-up Program (SFP) as the current standard of care is to improve the quality of radiotherapy for head and neck

  • 7 views
  • 19 Sep, 2021
  • 1 location